Search results for "Anticoagulation"
Stewardship, stroke mimics
Summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2020/03/recent-research.htm
15 Mar 2020
ACC and AHA update performance measures for STEMI and NSTEMI
The update has 17 performance measures, including four new ones, and seven quality measures, all of them new.
https://acphospitalist.acponline.org/weekly/archives/2017/09/27/2.htm
27 Sep 2017
Pulmonary embolism
For optimal documentation, coding, and reimbursement, the location or type of pulmonary embolism needs to be clearly identified.
https://acphospitalist.acponline.org/archives/2022/02/23/coding-corner-pulmonary-embolism.htm
23 Feb 2022
The COVID Yogi
“I control bipolar with an hour of yoga every day at home. I will get through this if I focus.”
https://acphospitalist.acponline.org/archives/2020/11/the-covid-yogi.htm
15 Nov 2020
Subsegmental pulmonary embolism
An example patient with sickle cell disease provides a lesson in diagnosing subsegmental pulmonary embolism.
https://acphospitalist.acponline.org/archives/2019/02/expert-analysis-subsegmental-pulmonary-embolism.htm
15 Feb 2019
Updated guidelines released on antithrombotic therapy for afib
The American College of Chest Physicians provided 60 recommendation statements in the areas of stroke risk, bleeding risk, antithrombotic therapy, and management of bleeding on oral anticoagulation, among other topics.
https://acphospitalist.acponline.org/weekly/archives/2018/08/29/5.htm
29 Aug 2018
Standardized rounds, antibiotics and acute kidney injury, and more
Summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2017/06/in-the-news.htm
15 Jun 2017
Reports and recommendations on clot concerns with adenovirus COVID-19 vaccines
Based on reports of cerebral venous sinus thrombosis with the Johnson & Johnson (Janssen) COVID-19 vaccine, federal officials recommended a pause in its use, which will be reconsidered on April 23.
https://acphospitalist.acponline.org/weekly/archives/2021/04/21/1.htm
21 Apr 2021
Latest research, recommendations cover diabetes, clots, and remdesivir in COVID-19
Mortality was lower in diabetes patients given sitagliptin at admission for COVID-19, ACP practice points support remdesivir, acquired thrombophilia does not predict clots, cardiac arrest survival is low, and admissions for other conditions were still way down over the summer.
https://acphospitalist.acponline.org/weekly/archives/2020/10/07/1.htm
7 Oct 2020
Rivaroxaban after discharge may reduce thromboembolic risk in medically ill
An industry-funded trial that gave medical patients rivaroxaban for 45 days after hospital discharge found decreased risk for a composite end point of symptomatic venous thromboembolism, myocardial infarction, nonhemorrhagic stroke, and cardiovascular death compared to placebo.
https://acphospitalist.acponline.org/weekly/archives/2020/06/24/3.htm
24 Jun 2020